PAMELA MYERS: Open Payments
NPI 1720129380 · NORTH WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 101 payments from 22 companies in 2025. Trend: 2023 $1,924 · 2024 $1,885 · 2025 $1,714
Food & beverage: $1,707Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $296 |
| Ardelyx, Inc. | 11 | $170 |
| Lilly USA, LLC | 8 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $139 |
| Novo Nordisk Inc | 7 | $137 |
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| PFIZER INC. | 5 | $103 |
| Exact Sciences Corporation | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| GlaxoSmithKline, LLC. | 3 | $57 |
Products named: IBSRELA, CAPLYTA, UBRELVY, Wegovy, NURTEC ODT, QULIPTA, AIRSUPRA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
